Licensing Agreements
PreMD retains license agreement for cancer patents
Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007
Under terms of the agreement, PreMD has entered into an amendment of the existing licensing agreement relating to two existing U.S. and Japanese patents for a technology that detects a carbohydrate marker associated with cancerous and pre-cancerous conditions. The new arrangements reduce the royalty payable by PreMD to 7.5% from 10% on its revenues...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Addiction Medicine
Findings from Center for Addiction and Mental Health broaden understanding of addiction medicine - Anxiety Disorders Quality of Care
Research from National Institute on Alcohol Abuse and Alcoholism yields new data on anxiety disorders quality of care - Business & Finance
ArthroCare expects fourth quarter 2006 revenues of approximately $69.7 million - Business & Finance
Cambridge Heart expects total revenue for 2007 to range between $12 and $14 million - Business & Finance
Celgene Corporation reviews 2006 achievements and announces 2007 financial outlook - Business & Finance
Critical Therapeutics reports preliminary operating results for fourth quarter of 2006 - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
